Stay updated on SpFN Vaccine with ALFQ Adjuvant Clinical Trial
Sign up to get notified when there's something new on the SpFN Vaccine with ALFQ Adjuvant Clinical Trial page.

Latest updates to the SpFN Vaccine with ALFQ Adjuvant Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov record for the Phase 1 SpFN COVID-19 vaccine study is displayed, including its completed status, eligibility criteria, study arms, and outcome measures. It also includes study dates, collaborators, a publication, and an informed consent form.SummaryDifference62%

- Check15 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 instead of v3.7.2, while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces an NIH website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision indicator changed from v3.7.0 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the usual study details with an access restriction notice. This prevents viewing the trial record content and navigation as presented on the page.SummaryDifference21%

- Check77 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, reflecting a minor metadata/version update. This indicates a small maintenance or update to the page rather than a change to study details or user-facing content.SummaryDifference0.1%

Stay in the know with updates to SpFN Vaccine with ALFQ Adjuvant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SpFN Vaccine with ALFQ Adjuvant Clinical Trial page.